Health

FDA's historic approval of a CAR-T-based prostate cancer gene therapy marks a turning point in oncology, but cost and complexity loom.

The FDA's new dementia trial guidance aims to accelerate drug development but raises serious ethical concerns about informed consent.

An FDA panel rejected a specific strain update for the fall COVID-19 vaccine, revealing tensions between scientific data and real-world readiness.